Network origin in Jesse Cotari first degree
Entity | Entity type | Industry | |
---|---|---|---|
ImmuneBridge, Inc.
ImmuneBridge, Inc. BiotechnologyHealth Technology ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018.
5
| Holding Company | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jesse Cotari via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
CAMBREX CORPORATION | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
StemCyte, Inc.
StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Biotechnology | Director/Board Member | |
NeoStem Oncology LLC
NeoStem Oncology LLC Pharmaceuticals: MajorHealth Technology NeoStem Oncology LLC is focused on the production and supply of clinically relevant embryonic stem cell derived human cell populations. Founded in 2005, the mission of NeoStem Oncology is to catalyze the efficient development of human therapies based on human embryonic stem cells. The key to this goal is the production and supply of clinically relevant human cell populations using a scalable, efficient and highly reproducible process. They generate human embryonic stem cell (hESC) lines, expand them to clinically and commercially useful numbers, and differentiate them at extremely high purity using fully-defined, proprietary media and GMP processes that are FDA compliant from day one. And they do this at a fraction of the cost of conventional cell manufacturing. As a result, the company can economically supply large quantities of high purity cells for its own clinical development pipeline in specific application areas. It can also supply high purity, fully characterized, clinically relevant human cell populations to companies or other institutions for development of therapies, efficacy screening or creation of toxicity profiles for candidate drugs, or experimental research. NeoStem Oncology LLC is a privately held Delaware Corporation with headquarters and research facilities in Irvine, CA. | Pharmaceuticals: Major | Director/Board Member | |
Integrated Plasmonics Corp.
Integrated Plasmonics Corp. SemiconductorsElectronic Technology Integrated Plasmonics Corp. operates as a nanotechnology company. The company was founded on February 4, 2011 and is headquartered in San Francisco, CA. | Semiconductors | Founder | |
Michigan State University | College/University | Undergraduate Degree | |
Morrison & Foerster LLP
Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Morrison & Foerster LLP is a law firm that provides legal services on various industries, which include: litigation, financial services, intellectual property and technology, and transactional work, such as corporate, capital markets and real estate finance representations. The company was founded in 1883 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Insight Venture Management LLC
Insight Venture Management LLC Investment ManagersFinance Insight Venture Management LLC (Insight Venture Partners) is a private equity/ venture capital subsidiary of Insight Holdings Group LLC founded in 1995 by Jeffrey L. Horing and Jerry Fred Murdock. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
CRV LLC
CRV LLC Investment ManagersFinance Charles River Ventures, Inc. is a venture capital firm founded in 1970. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
University of Cambridge | College/University | Graduate Degree | |
Poietic Technologies, Inc.
Poietic Technologies, Inc. Chemicals: SpecialtyProcess Industries Part of Cambrex Corp., Poietic Technologies, Inc. supplies normal human cells of hematopoietic origin. The company is based in Gaithersburg, MD. The company was founded by Kim Warren. Poietic Technologies was acquired by Cambrex Corp. on December 28, 1998 for $2.50 million. | Chemicals: Specialty | Founder | |
University of Maryland | College/University | Doctorate Degree | |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Anthem Venture Management LLC
Anthem Venture Management LLC Investment ManagersFinance Anthem Venture Management LLC (Anthem Venture Management) is a venture capital firm founded in 2000. The firm is headquartered in Santa Monica, California. | Investment Managers | Corporate Officer/Principal | |
Lonza Walkersville, Inc.
Lonza Walkersville, Inc. Pharmaceuticals: MajorHealth Technology Lonza Walkersville, Inc. develops, manufactures and provides testing services for cell-based therapeutics. Its services include life-science customers, research organizations, pharmaceutical, biopharmaceutical, biotechnology and generic drug companies. The company was founded was founded on May 9, 1991 and is headquartered in Walkersville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The International Society for Stem Cell Research | Corporate Officer/Principal | ||
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Investment Managers | Founder | |
VISTAGEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
University of California | College/University | Doctorate Degree | |
Lemnos Labs, Inc.
Lemnos Labs, Inc. Investment ManagersFinance Lemnos Labs Inc (Lemnos Labs) is a venture capital firm founded in 2011 by Jeremy Conrad and Helen Zelman Boniske. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Analyst | |
Proteus LLC
Proteus LLC Investment ManagersFinance Part of Keystone International Holdings LLC, Proteus LLC is a company that offers a complete accredited investor solution for investing in alternative assets. The company is based in Indianapolis, IN. The company provides opportunities for sophisticated investors, advisors, institutions, managers, and sponsors. Proteus offers a world-class analytical engine and private investing, allowing for smarter investing and better control. The company was founded by Gregory A. Bonfiglio. Gregory A. Bonfiglio has been the CEO since incorporation. | Investment Managers | Chief Executive Officer | |
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
HEALIOS K.K. | Pharmaceuticals: Major | Director/Board Member | |
The University of Michigan Law School | College/University | Graduate Degree | |
Sourcery Technologies, Inc.
Sourcery Technologies, Inc. Packaged SoftwareTechnology Services Sourcery Technologies, Inc. develops a payments and commerce platform that focuses on the wholesale foodservice industry. Its features include invoice storage, analytics, online bill pay and high touch services. The company was founded by Na’ama Moran and Peretz Partensky in July 2012 and is headquartered in San Francisco, CA. | Packaged Software | Founder | |
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Deciduous Therapeutics, Inc.
Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Dyno Therapeutics, Inc.
Dyno Therapeutics, Inc. BiotechnologyHealth Technology Dyno Therapeutics, Inc. engages in the development of therapeutics technologies. It develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. The company was founded by Kelsic Eric David and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member | |
Unlearn.AI, Inc.
Unlearn.AI, Inc. Packaged SoftwareTechnology Services Unlearn.AI, Inc. develops machine learning technology for clinical drug trails. It offers clinical trial design, synthetic control arms, and super-powered subgroup analysis. The company was founded by Aaron Smith, Charles K. Fisher, and Jonathan Walsh in 2017 and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Evernow, Inc.
Evernow, Inc. Medical/Nursing ServicesHealth Services Evernow, Inc. provides women health care services. The firm offers hot flashes, weight gain, brain fog, sleep problems, vaginal dryness, mood swings, fatigue, night sweats and urgent peeing services. The company is headquartered in San Francisco, CA. | Medical/Nursing Services | Chief Executive Officer | |
Switch Therapeutics, Inc.
Switch Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Switch Therapeutics, Inc. is an American biotechnology company that aims to treat a range of diseases affecting the central nervous system and systemic indications with significant unmet need. Switch is based in , and was founded by Dee Datta, who has been the CEO since incorporation. The company is pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science. The company's novel gene knockdown approach, the Conditionally Activated siRNA (CASI) platform, is based on technology developed by renowned researchers in the field of RNA and drug development from Caltech, Harvard Medical School, and City of Hope. | Pharmaceuticals: Major | Director/Board Member | |
Gameto, Inc.
Gameto, Inc. BiotechnologyHealth Technology Gameto, Inc. is a biotechnology company based in New York, NY that focuses on developing novel treatment solutions for women's health, starting with infertility. The company's lead program, Fertilo, aims to make IVF and egg freezing shorter, safer, and more accessible through reduced hormonal injections by maturing eggs outside of the body. The company's goal is to improve assisted fertility outcomes, make the medical burden of menopause optional, and redefine female reproductive health by testing and developing drugs for ovarian disease. Gameto is led by CEO Dina Radenkovic, a physician-turned-entrepreneur, and Chairman Martin Varsavsky, a serial entrepreneur and founder of the largest fertility network, Prelude Fertility. | Biotechnology | Director/Board Member | |
ArrePath, Inc.
ArrePath, Inc. Information Technology ServicesTechnology Services ArrePath, Inc. is an anti-infective drug discovery company that focuses on addressing the health challenge of drug-resistant infections. The platform's proof-of-concept has been demonstrated in studies published in Cell by ArrePath's scientific founder, Zemer Gitai, Ph.D., Edwin Grant Conklin Professor of Biology at Princeton University. The company is based in Princeton, NJ, and is funded by the Boehringer Ingelheim Venture Fund, Insight Partners, Innospark Ventures, Viva BioInnovator, Arimed Capital, PTX Capital, and Nor'easter Ventures. The company utilizes a proprietary machine learning-based platform to efficiently identify anti-infective agents with new mechanisms of action at the outset of the discovery process. This is achieved through a deep understanding and analysis of pathogen behavior. The CEO of the company is Lloyd J. Payne. | Information Technology Services | Director/Board Member | |
Horizon Education LLC
Horizon Education LLC Miscellaneous Commercial ServicesCommercial Services Horizon Education LLC offers postsecondary readiness programs to help high school students prepare for graduation and college entrance exams. The company is based in Laguna Beach, CA. The company was founded in 2013 by Dustin Bainbridge and Michelle Sauceda. Dustin Bainbridge has been the CEO since 2013. Horizon Education was acquired by Progress Learning LLC on June 23, 2022. | Miscellaneous Commercial Services | Chief Operating Officer | |
DEM BioPharma, Inc.
DEM BioPharma, Inc. Pharmaceuticals: MajorHealth Technology DEM BioPharma, Inc. is an American company that pioneers the next generation of immunotherapeutics to eliminate tumors by targeting 'don't eat me' and 'eat me' signals on cancer cells, macrophages, and other myeloid effector cells. The company is based in Cambridge, MA. The proprietary CHOMP™ platform utilizes CRISPR-based functional genomic screens to discover and validate new signals that could enhance cancer cell elimination through increased phagocytosis. The company was founded by Longwood Fund and builds on groundbreaking functional genomics research and discoveries in macrophage biology from its scientific co-founders. Nenad Grmusa has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member | |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Biotechnology | Director/Board Member | |
Vecprobio Inc.
Vecprobio Inc. Packaged SoftwareTechnology Services Vecprobio Inc. develops manufacturing technologies and tools for gene therapy. The company is based in San Diego, CA. The company was founded in 2022. Daniel Gibbs has been the CEO of the company since 2022. | Packaged Software | Chairman | |
Superluminal Medicines Inc
Superluminal Medicines Inc BiotechnologyHealth Technology Superluminal Medicines Inc is a generative biological and chemical company. The company is based in Boston, MA. The CEO of the company is Cony D'Cruz. | Biotechnology | Director/Board Member |
Statistics
International
United States | 37 |
Canada | 3 |
United Kingdom | 2 |
Japan | 2 |
Sectoral
Health Technology | 17 |
Finance | 8 |
Technology Services | 6 |
Consumer Services | 6 |
Commercial Services | 4 |
Operational
Director/Board Member | 19 |
Founder | 8 |
Corporate Officer/Principal | 5 |
Private Equity Investor | 4 |
Chief Executive Officer | 3 |
Most connected contacts
Insiders | |
---|---|
Gregory Bonfiglio | 16 |
Dylan Morris | 14 |
Kim Warren | 8 |
Peretz Partensky | 6 |
Alicia Marie Jackson | 2 |
- Stock Market
- Insiders
- Jesse Cotari
- Company connections